Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.

导出 OA

翻译打印收藏纠错

作者： Baowen,Yu ^[1] ; Moran,Hu ^[1] ; Wanzi,Jiang ^[1] ; Yizhe,Ma ^[1] ; Jingya,Ye ^[1] ; Qinyi,Wu ^[1] ; Wen,Guo ^[1] ; Yan,Sun ^[1] ; Min,Zhou ^[1] ; Yiwen,Xu ^[1] ; Zhoulu,Wu ^[1] ; Yiwen,Wang ^[1] ; Sin Man,Lam ^[2] ; Guanghou,Shui ^[2] ; Jingyu,Gu ^[1] ; John Zhong,Li ^[3] ; Zhenzhen,Fu ^[4] ; Yingyun,Gong ^[5] ; Hongwen,Zhou ^[6]

作者单位： Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. ^[1] Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. ^[2] Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China. ^[3] Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. zhenzhen1127@foxmail.com. ^[4] Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. gongyingyun@njmu.edu.cn. ^[5] Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. drhongwenzhou@njmu.edu.cn. ^[6] Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, China. drhongwenzhou@njmu.edu.cn. ^[7]

关键词 Cardiovascular disease Cer d18:1/24:1 Ceramide Metabolically unhealthy obesity

主题词成年人(Adult);人类(Humans);神经酰胺类(Ceramides);肥胖症(Obesity);胰岛素抗药性(Insulin Resistance);危险因素(Risk Factors);人体质量指数(Body Mass Index)

DOI 10.1186/s12944-023-01921-0

PMID 37794463

发布时间 2023-11-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交